Organon (OGN) Receivables - Net (2020 - 2026)
Organon (OGN) posted quarterly Receivables - Net of $1.5 billion for Q2 2026, up 0.54% year-over-year from $1.5 billion in Q2 2025, and up 7.8% on a QoQ basis from $1.4 billion in Q1 2026.
Organon (OGN) Receivables - Net (2020 - 2026) Analysis & Trends
Organon has reported Receivables - Net for 7 years, with the latest figure at $1.5 billion in Q2 2026.
- Receivables - Net for Q2 2026 came in at $1.5 billion, up 0.54% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.5 billion (up 0.54% YoY), and the FY2025 annual result was $1.3 billion, down 1.99% from the prior year.
- Receivables - Net climbed to $1.5 billion in Q2 2026, from $1.4 billion in the prior quarter.
- Over five years, Receivables - Net peaked at $1.7 billion in Q4 2023 and troughed at $1.3 billion in Q1 2022.
- A 5-year average of $1.5 billion and a median of $1.5 billion in 2025 frame the typical range for Receivables - Net.
- The widest annual swing landed in 2022, when Receivables - Net jumped 30.89%; it then slipped 22.13% in 2024.
- A 5-year view of Receivables - Net shows it stood at $1.5 billion in 2022, then climbed by 18.24% to $1.7 billion in 2023, then fell by 22.13% to $1.4 billion in 2024, then fell by 1.99% to $1.3 billion in 2025, then rose by 12.1% to $1.5 billion in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $1.5 billion in Q2 2026, $1.4 billion in Q1 2026, and $1.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Bn |
| Jun 30, 2026 | 1.49 Bn |
| Mar 31, 2026 | 1.38 Bn |
| Mar 31, 2026 | 1.38 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.48 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.69 Bn |
| Sep 30, 2024 | 1.69 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.55 Bn |